|
Normal
|
Disease state |
|
|
None
|
Compound treatment |
|
|
Pan troglodytes
|
Organism |
|
|
Homo sapiens
|
Organism |
|
|
Epithelial cell
|
Cell type |
|
|
Primary
|
Disease staging |
|
|
Stromal cell
|
Cell type |
|
|
Cerebellum
|
Organism part |
|
|
FLAP
|
Compound treatment |
|
|
Not applicable
|
Histology |
|
|
Breast carcinoma
|
Disease state |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
N/a
|
Test result |
|
|
MK886
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
Dimethyl sulfoxide
|
Compound treatment |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Peripheral blood
|
Organism part |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Uninfected
|
Infection |
|
|
Huntington's disease
|
Disease state |
|
|
HL-60
|
Cell line |
|
|
Cystic change
|
Histology |
|
|
Liver
|
Organism part |
|
|
Endothelial cell
|
Cell type |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
BT-474
|
Cell line |
|
|
Lymph node metastasis
|
Disease staging |
|
|
Hydroxyurea
|
Compound treatment |
|
|
Adult
|
Developmental stage |
|
|
Fibroblast
|
Cell type |
|
|
HeLa
|
Cell line |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
Caudate nucleus
|
Organism part |
|
|
MCF7
|
Cell line |
|
|
White blood cells
|
Organism part |
|
|
Epilepsy
|
Disease state |
|
|
Macaca mulatta
|
Organism |
|
|
SKMEL5
|
Cell line |
|
|
Grade IV
|
Tumor grading |
|
|
Glioblastoma
|
Disease state |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
Ultraviolet light
|
Light |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
MDA468
|
Cell line |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
MDA-MB-231
|
Cell line |
|
|
Stage II
|
Disease staging |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Chondrocyte
|
Cell type |
|
|
T3aNxM1
|
Disease staging |
|
|
Hypericin incubated, not irrad...
|
Growth condition |
|
|
Hypericin incubated, irradiate...
|
Growth condition |
|
|
Rapamycin
|
Compound treatment |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Epidermal keratinocyte
|
Cell type |
|
|
SkinEthic keratinocyte
|
Cell type |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Control
|
Compound treatment |
|
|
BL41K3
|
Cell line |
|
|
BJABK3
|
Cell line |
|
|
MCF10A
|
Cell line |
|
|
HPL1
|
Cell line |
|
|
HaCaT
|
Cell line |
|
|
Kidney
|
Organism part |
|
|
SKBR3
|
Cell line |
|
|
Stage I
|
Disease staging |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
None
|
Light |
|
|
Spermatid
|
Cell type |
|
|
Testis
|
Organism part |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
SsMCF7
|
Cell line |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
Spermatocyte
|
Cell type |
|
|
PCep4 control vector transfect...
|
Gene modification |
|
|
ETat plasmid transfection
|
Gene modification |
|
|
Seminiferous tubule
|
Organism part |
|
|
Oligodendroglioma
|
Disease state |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
Granulocyte
|
Cell type |
|
|
M1 macrophage
|
Cell type |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
PC3
|
Cell line |
|
|
Grade III
|
Tumor grading |
|
|
Skeletal muscle
|
Organism part |
|
|
Interferon-gamma + lipopolysac...
|
Compound treatment |
|
|
Cartilage
|
Organism part |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
Superior cervical ganglion
|
Organism part |
|
|
Affymetrix Labeling
|
Protocol type |
|
|
Fetal bovine serum in media
|
Growth condition |
|
|
Geriatric
|
Developmental stage |
|
|
Pediatric
|
Developmental stage |
|
|
Gorilla gorilla
|
Organism |
|
|
Native skin
|
Cell type |
|
|
Cadmium chloride 2.5-hydrate
|
Compound treatment |
|
|
Heregulin
|
Compound treatment |
|
|
Lung
|
Organism part |
|
|
T3bN1M0
|
Disease staging |
|
|
HMEC184
|
Cell line |
|
|
Trigeminal ganglion
|
Organism part |
|
|
ERbeta transfected
|
Genotype |
|
|
Caco-2
|
Cell line |
|
|
Synovial fluid
|
Organism part |
|
|
Normal
|
Histology |
|
|
Keratinocyte
|
Cell type |
|
|
MiR15a/miR16-1 transfection
|
Gene modification |
|
|
Normal2
|
Replicate |
|
|
Serum starvation + thymidine b...
|
Growth condition |
|
|
Methotrexate
|
Compound treatment |
|
|
Tumor
|
Organism part |
|
|
Phenol
|
Compound treatment |
|
|
T3aNxMx
|
Disease staging |
|
|
Measles virus Chicago-1 strain
|
Infection |
|
|
Brain
|
Organism part |
|
|
Acute radiation toxicity
|
Clinical history |
|
|
5-aza-2'-deoxycytidine + trich...
|
Compound treatment |
|
|
Bone marrow
|
Organism part |
|
|
BT474
|
Cell line |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
M-CSF
|
Compound treatment |
|
|
T3bN0M0
|
Disease staging |
|
|
Primary gastric tumor
|
Organism part |
|
|
Experimental malaria-infected
|
Disease state |
|
|
Benign nevi
|
Disease state |
|
|
Carboplatin resistant
|
Test result |
|
|
Carboplatin sensitive
|
Test result |
|
|
GLI60
|
Cell line |
|
|
Nickel(II) chloride hexahydrat...
|
Compound treatment |
|
|
IL-4
|
Compound treatment |
|
|
Amygdala
|
Organism part |
|
|
U937
|
Cell line |
|
|
Astrocyte
|
Cell type |
|
|
DMSO
|
Vehicle |
|
|
Pan paniscus
|
Organism |
|
|
Pons
|
Organism part |
|
|
Obesity
|
Disease state |
|
|
T-cell acute lymphoblastic leu...
|
Disease state |
|
|
Infrared light
|
Light |
|
|
A549
|
Cell line |
|
|
Whole blood
|
Organism part |
|
|
Occipital lobe
|
Organism part |
|
|
Doxycycline
|
Compound treatment |
|
|
Dermatomyositis
|
Disease state |
|
|
Ethanol
|
Vehicle |
|
|
AdERb high moi
|
Gene modification |
|
|
Prostate cancer
|
Disease state |
|
|
Thymus
|
Organism part |
|
|
Skin substitute
|
Cell type |
|
|
Dendritic cell
|
Cell type |
|
|
Macrophage
|
Cell type |
|
|
Empty vector
|
Gene modification |
|
|
GLI72
|
Cell line |
|
|
LacZ control
|
RNAi |
|
|
HTERT transduced
|
Gene modification |
|
|
CD3int CD4+ CD8+
|
Phenotype |
|
|
Double positive thymocyte
|
Cell type |
|
|
Prefrontal cortex
|
Organism part |
|
|
Astrocytoma
|
Disease state |
|
|
Enzo Labeling
|
Protocol type |
|
|
Johnsen score count 3.2: Serto...
|
Histology |
|
|
PEL-5
|
Cell line |
|
|
IL-20
|
Compound treatment |
|
|
MCF-7
|
Cell line |
|
|
Blood
|
Organism part |
|
|
Umbilical cord
|
Organism part |
|
|
Fetus
|
Developmental stage |
|
|
R-(-)-apomorphine HCl
|
Compound treatment |
|
|
ITS medium
|
Growth condition |
|
|
Ovary
|
Organism part |
|
|
Trichostatin A
|
Compound treatment |
|
|
IMP(1,3)B
|
RNAi |
|
|
Primary fibroblast
|
Cell type |
|
|
TIVE
|
Cell line |
|
|
Medulla oblongata
|
Organism part |
|
|
Female
|
Sex |
|
|
Male
|
Sex |
|
|
Johnsen score count 10: full s...
|
Histology |
|
|
Metastatic
|
Disease staging |
|
|
Cingulate cortex
|
Organism part |
|
|
Smooth muscle
|
Organism part |
|
|
Johnsen score count 5: no sper...
|
Histology |
|
|
M2 macrophage
|
Cell type |
|
|
Childhood acute myeloid leukem...
|
Disease state |
|
|
Secretory cell
|
Cell type |
|
|
HMT3522S1
|
Cell line |
|
|
Infant
|
Developmental stage |
|
|
Anaplastic oligodendroglioma
|
Disease state |
|
|
Relapse 0; ER status ER-; brai...
|
Clinical info |
|
|
Endometrioid carcinoma
|
Disease state |
|
|
Grade II
|
Tumor grading |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
Training set
|
Population |
|
|
Test set
|
Population |
|
|
MDS-associated acute myeloid l...
|
Disease state |
|
|
Acute myeloid leukemia
|
Disease state |
|
|
Cyclosporin A, mycophenolate m...
|
Clinical treatment |
|
|
Sirolimus, mycophenolate mofet...
|
Clinical treatment |
|
|
Braak stage 1
|
Disease staging |
|
|
Monocyte at intermediate diffe...
|
Cell type |
|
|
Cerebellum peduncles
|
Organism part |
|
|
MKN74
|
Cell line |
|
|
Heart
|
Organism part |
|
|
ERalpha/beta transfected
|
Genotype |
|
|
X-linked chronic granulomatous
|
Disease state |
|
|
Vanadium pentoxide
|
Compound treatment |
|
|
Subthalamic nucleus
|
Organism part |
|
|
CodeLink Labeling
|
Protocol type |
|
|
Astrocytic tumor
|
Disease state |
|
|
Oligodendroglioma with 1p19q c...
|
Disease state |
|
|
Nocodazole
|
Compound treatment |
|
|
Malignant pleural mesothelioma
|
Disease state |
|
|
Actinomycin D
|
Compound treatment |
|
|
Cigarette smoke
|
Growth condition |
|
|
Incubator control
|
Growth condition |
|
|
Met5A
|
Cell line |
|
|
Anaplastic mixed oligo-astrocy...
|
Disease state |
|
|
Mercaptopurine, methotrexate
|
Compound treatment |
|
|
Multiple myeloma
|
Disease state |
|
|
Renal dysfunction without reje...
|
Clinical info |
|
|
WE 68
|
Cell line |
|
|
2-(3,4,5-trimethoxy-phenylamin...
|
Compound treatment |
|
|
PT3
|
Disease staging |
|
|
Control
|
RNAi |
|
|
SIM2s
|
RNAi |
|
|
Serum starvation synchronizati...
|
Growth condition |
|
|
Ischemic cardiomyopathy
|
Disease state |
|
|
Mannitol
|
Compound treatment |
|
|
Decrease in symptoms
|
Clinical info |
|
|
Well-functioning transplant
|
Clinical info |
|
|
Neutrophil
|
Cell type |
|
|
Adipose tissue
|
Organism part |
|